Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology
Open Access
- 1 October 2015
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 28 (10), 1360-1368
- https://doi.org/10.1038/modpathol.2015.87
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- IMP3 and GLUT-1 Immunohistochemistry for Distinguishing Benign From Malignant Mesothelial ProliferationsThe American Journal of Surgical Pathology, 2013
- A Distinct Subset of Atypical Spitz Tumors is Characterized by BRAF Mutation and Loss of BAP1 ExpressionThe American Journal of Surgical Pathology, 2012
- Prognosis and prognostic factors of patients with mesothelioma: a population-based studyBritish Journal of Cancer, 2012
- Frequent inactivation of the BAP1 gene in epithelioid‐type malignant mesotheliomaCancer Science, 2012
- Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancersJournal of Medical Genetics, 2011
- Germline BAP1 mutations predispose to malignant mesotheliomaNature Genetics, 2011
- Germline mutations in BAP1 predispose to melanocytic tumorsNature Genetics, 2011
- The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesotheliomaNature Genetics, 2011
- Malignant mesothelioma: Facts, Myths, and HypothesesJournal of Cellular Physiology, 2011
- Usefulness of EMA, GLUT-1, and XIAP for the Cytologic Diagnosis of Malignant Mesothelioma in Body Cavity FluidsAmerican Journal of Clinical Pathology, 2009